HOME >> MEDICINE >> NEWS
Advances in Uterine Leiomyoma Research: 2nd NIH International Congress

WHAT: The National Institutes of Health will host "Advances in Uterine Leiomyoma Research: 2nd NIH International Congress" on February 24 25. This conference will bring together researchers working in the fields of biomedicine, epidemiology, basic research, therapeutics, and translational medicine to foster an exchange of scientific information among members of the uterine leiomyoma (fibroids) research and health care communities. Fibroids are the most common gynecologic neoplasm in women of reproductive age and the leading cause of hysterectomy in the United States. Topics to be covered include Clinical Experiences and Therapeutic Strategies, Epidemiology, Clinical Trials, Pathogenesis of Smooth Muscle Tumors, and Molecular and Genetics Characteristics.

WHEN: February 24-25, 2005

WHERE: Natcher Conference Center, National Institutes of Health Bethesda, MD 20892

WHO: This conference will be co-chaired by Dr. Vivian Pinn, Associate Director for Women's Health and Director, Office of Research on Women's Health (ORWH), NIH and Dr. Kenneth Olden, Director, National Institute of Environmental Health Sciences, NIH. Program co-chairs include Dr. J. Carl Barrett, National Cancer Institute (NCI), Drs. Estella Parrott and James Segars, National Institute of Child Health and Human Development (NICHD), and Dr. Barbara J. Davis, AstraZeneca. Participants will represent academia, medical centers, government, industry, and advocacy groups.

NOTE TO EDITORS: This congress is a joint effort within the Department of Health and Human Services, including the NIH ORWH, NIEHS, NICHD, NCI, National Institute of Biometry and Biomedical Sciences (NIBIB), National Center for Research Resources (NCRR), and the following DHHS entities: Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Health Research and Services Administration (HRS
'"/>

Contact: Vicki Malick, NIH Office of Research on Womens Health
301-402-1770
NIH/Office of the Director
17-Feb-2005


Page: 1 2

Related medicine news :

1. Advances in plasma physics at Annual APS Meeting
2. Advances in plasma physics at Annual APS Meeting
3. Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder
4. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
5. Advances emerging in hepatitis management
6. Advances in prevention and treatment research hold promise for pipeline
7. Advances in MRI imaging may lead to new standards for faster diagnosis of multiple sclerosis
8. Peanut Allergy: Major Advances in Treatment and Education
9. "Radical" Discovery Advances Medicine and Plastics
10. Advances in On the Spot tests have huge public health implications
11. Immunex Advances CD40 Ligand To Phase II Clinical Trial In People With Metastatic Kidney Cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology:
Cached News: